Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012.
暂无分享,去创建一个
Janet J. Hamilton | J. Ward | S. Holmberg | D. Church | K. Sweet | U. Sharapov | R. Tohme | Fujie Xu | B. Kupronis | Sheila M. Guilfoyle | Marisa Stanley | A. Suryaprasad | Stephen J. Liu | K. Macomber | K. Iqbal | Jianglan Z. White | K. Barton | B. Eichler | Ami Patel | Shadia Bel Hamdounia | Chardé Fisher | Benjamin A. Kupronis
[1] R. Valdiserri,et al. Breaking the Silence on Viral Hepatitis , 2014, Annals of Internal Medicine.
[2] T. Richards,et al. Methods for improving the quality and completeness of mortality data for American Indians and Alaska Natives. , 2014, American journal of public health.
[3] D. Holtzman,et al. Confronting the emerging epidemic of HCV infection among young injection drug users. , 2014, American journal of public health.
[4] Deborah D Ingram,et al. 2013 NCHS Urban-Rural Classification Scheme for Counties. , 2014, Vital and health statistics. Series 2, Data evaluation and methods research.
[5] S. Holmberg,et al. Estimating acute viral hepatitis infections from nationally reported cases. , 2014, American journal of public health.
[6] C. Cunningham,et al. Changes in testing for human immunodeficiency virus, sexually transmitted infections, and hepatitis C virus in opioid treatment programs. , 2013, JAMA.
[7] R. Schinazi,et al. Treatment as prevention and cure towards global eradication of hepatitis C virus. , 2013, Trends in microbiology.
[8] V. Moyer,et al. Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement , 2013, Annals of Internal Medicine.
[9] M. Hellard,et al. Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals , 2013, Hepatology.
[10] J. Hahn,et al. Injection drug use and hepatitis C virus infection in young adult injectors: using evidence to inform comprehensive prevention. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] Leonard J. Paulozzi,et al. Vital Signs: Overdoses of Prescription Opioid Pain Relievers and Other Drugs Among Women — United States, 1999–2010 , 2013, MMWR. Morbidity and mortality weekly report.
[12] T. Liang,et al. Current and future therapies for hepatitis C virus infection. , 2013, The New England journal of medicine.
[13] J. Havens,et al. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. , 2013, American journal of public health.
[14] Kenneth E. Carlson,et al. Geographic variation in opioid prescribing in the U.S. , 2012, The journal of pain : official journal of the American Pain Society.
[15] J. Havens,et al. Hepatitis C viremia and genotype distribution among a sample of nonmedical prescription drug users exposed to HCV in rural Appalachia , 2012, Journal of medical virology.
[16] Rebecca L Morgan,et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. , 2012, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[17] J. Bruneau,et al. The rising prevalence of prescription opioid injection and its association with hepatitis C incidence among street-drug users. , 2012, Addiction.
[18] R. Monina Klevens,et al. The Increasing Burden of Mortality From Viral Hepatitis in the United States Between 1999 and 2007 , 2012, Annals of Internal Medicine.
[19] Grant T. Baldwin,et al. CDC grand rounds , 2012 .
[20] D. D. Ingram,et al. NCHS urban-rural classification scheme for counties. , 2012, Vital and health statistics. Series 2, Data evaluation and methods research.
[21] Christopher M. Jones,et al. CDC Grand Rounds: Prescription Drug Overdoes - A U.S. Epidemic , 2012 .
[22] D. D. Des Jarlais,et al. Systematic Review and Meta-Analysis of Interventions to Prevent Hepatitis C Virus Infection in People Who Inject Drugs , 2011 .
[23] Hepatitis C virus infection among adolescents and young adults:Massachusetts, 2002-2009. , 2011, MMWR. Morbidity and mortality weekly report.
[24] Leonard J. Paulozzi,et al. Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008. , 2011, MMWR. Morbidity and mortality weekly report.
[25] W. Christian,et al. Viral Hepatitis and Injection Drug Use in Appalachian Kentucky: A Survey of Rural Health Department Clients , 2010, Public health reports.
[26] L. Paulozzi,et al. Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004-2008. , 2010, MMWR. Morbidity and mortality weekly report.
[27] R. Klevens,et al. Population-based Surveillance for Hepatitis C Virus, United States, 2006–2007 , 2009, Emerging infectious diseases.
[28] J. Boivin,et al. Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience. , 2009, Drug and alcohol dependence.
[29] J. Ferrante,et al. Family physicians' knowledge and screening of chronic hepatitis and liver cancer. , 2008, Family medicine.
[30] Use of enhanced surveillance for hepatitis C virus infection to detect a cluster among young injection-drug users--new York, November 2004-April 2007. , 2008, MMWR. Morbidity and mortality weekly report.
[31] Rohan Jayasuriya,et al. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. , 2006, Addiction.
[32] D. Vlahov,et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. , 2003, American journal of epidemiology.
[33] M. Busch,et al. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. , 2002, The Journal of infectious diseases.
[34] Juliea Morris,et al. Statistics in Medicine: Calculating confidence intervals for relative risks (odds ratios) and standardised ratios and rates , 1988, British medical journal.